Combination of organic compounds

Details for Australian Patent Application No. 2005205914 (hide)

Owner Novartis AG

Inventors Feldman, David Louis

Agent Davies Collison Cave

Pub. Number AU-A-2005205914

PCT Pub. Number WO2005/070406

Priority 60/538,222 22.01.04 US

Filing date 21 January 2005

Wipo publication date 4 August 2005

International Classifications

A61K 31/454 (2006.01)

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/070406 Priority application(s): WO2005/070406

4 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005205915-Pyrazolo[1,5-a]pyrimidin-7-yl-amine derivatives for use in the treatment of protein kinase dependent diseases

2005205912-Monoparamunity inducers based on attenuated rabbit myxoma viruses